Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1639.30
7.65 (0.47%)
< Home < Back

Sun Pharmaceutical to invest additional Rs 200 crore in Assam plant

Date: 15-10-2018

Sun Pharmaceutical Industries is going to invest an additional Rs 200 crore at its Assam plant to augment operations. The company has already invested Rs 700 crore in this manufacturing facility.

Besides, the company has inaugurated a new production line at its facility in Palashbari.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.